Press Releases

Calidi is at the forefront of the genetic medicine revolution in cancer and other indications

Read the Latest

April 1, 2026

Press Release

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Read More

November 6, 2018

Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

SAN DIEGO, Nov. 6, 2018 — Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…

October 25, 2018

Calidi Biotherapeutics, Inc. Granted New Patent from USPTO for Cell-Based Delivery Of Oncolytic Vaccinia Viruses

SAN DIEGO, October 25, 2018 – Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…